Table 1.

Patient demographic and clinicopathologic characteristics

Median age, years (range)	62 (44–72)
Stage, n (%)
I	1 (5.6)
II	1 (5.6)
III	11 (61.1)
IV	5 (27.8)
Histology, n (%)
Serous	16 (88.9)
Clear cell	1 (5.6)
Endometrioid	1 (5.6)
Cytoreductive status, n (%)
Optimal	15 (83.3)
Suboptimal	3 (16.6)
Median primary treatment-free interval, months (%)	7 (0–39)
<6	7 (38.9)
6–12	8 (44.4)
>12	3 (16.6)
Median prior chemotherapy regimens (range)	3 (1–6)
Disease status, n (%)
Measurable	18 (100)
Evaluable	0 (0)

Note: Data are based on 18 patients.